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RESEARCH   PROTOCOL 
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COMPLICATIONS OF ILEOSTOMY CLOSURE: THE 
SOUTH AFRICAN EXPERIENCE 
Introduction 
Ileostomy closure is associated with considerable morbidity and mortality. 
Research Question 
To determine the complications of ileostomy closure and compare the rates of 
complications, at a tertiary teaching hospital in South Africa with that worldwide. 
Literature Review 
An elective loop ileostomy is commonly constructed to protect a distal anastomosis 
when there is a high risk of anastomotic leakage such as following low anterior 
resection and restorative proctocolectomy or for diversion purposes during 
emergency surgical procedures. 
Ileostomy closure is associated with significant morbidity. Most of the data 
concerning the complications following ileostomy closure come from a small 
number of reviews done in USA, Spain, Turkey and Europe. Reported morbidity 
rates are between 3-30% and mortality rate of 0-4%. It is only recently that a study 
demonstrated a major complication rate of 9.3% and a mortality rate of 0.6% among 
a total of 5,401 patients1. 
A recent study demonstrated the association between pre-operative 
hypoalbuminaemia and anaemia and a higher complication rate following ileostomy 
closure.2 The literature has also shown that there are no differences in complication 
rates whether a trainee or consultant performed the closure 3, however, there are 
lower rates of bowel obstruction and anastomotic leakage noted in patients with 
stapled anastomosis compared to hand sewn anastomosis4. There seems to be a 
higher complication rate following a longer interval between stoma formation and 
closure5. Neoadjuvant chemotherapy does not seem to predict the incidence of 
complications seen post closure¹. 
There are no studies done in South Africa demonstrating the complication rate 
following an ileostomy closure.  
Aims and Objectives: 
Previous literature pertaining to complications following ileostomy closure and 
possible risk factors associated with ileostomy closure have been seen derived 
largely from developed countries. South Africa has its own unique patient population 
dynamics with regards to the colorectal disease burden including the, time and age at 
presentation, genetic variability, access to health care facilities, financial security, 
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varying levels of social security and differences in sociocultural health seeking 
behaviour patterns. It would therefore be interesting to evaluate whether the type of 
complications seen at a tertiary teaching hospital in South Africa are comparable to 
that seen worldwide.  
Aim: To determine the complication rate after an ileostomy closure at Groote Schuur 
Hospital (GSH) between January 2008 and December 2012. 
 
Specific Objectives: 
 To determine if there are any surgical factors that may contribute to 
development of complications seen. 
 To determine if the technique of ileostomy closure has any influence on the 
complications seen. 
 To determine if the indication for the ileostomy has any association with the 
complications seen.  
 To determine if there are certain patient factors that may predispose to 
development of complications seen. 
 
 
Materials and Methods: 
A retrospective review of patients who underwent ileostomy closure at the colorectal 
unit, Groote Schuur Hospital, from January 2008 to December 2012 will be 
undertaken. 
The data will be collected from patient’s hospital folders. 
















1.Indication:          
Cancer          
IBD          
Emergency  
diversion                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
         
2.Comorbidity:          
Diabetes          
Hypertension          
Renal impairment          
COPD          
3.Smoking          
4.Performance 
Status: 
         
ASA 1          
ASA 2          
ASA 3          
ASA 4          
5.Type of closure:          
Hand sewn          
Stapled          
6.Experience level 
of surgeon:  
         
Junior Consultant          
Registrar          
7.Type of wound 
closure: 
         
Stapled          




         
9.Complications 
 
         
(A) Major:          
Anastomotic Leak          
Fistula          
Bowel 
Obstruction 
         
Stricture          
Incisional hernia          
(B) Medical: 
 
         
Pneumonia          
UTI          
DVT          
Line Sepsis          
Cardiac 
complications 
         
Renal Failure          
(C) Minor: 
 
         
Wound Infection          
Stitch Granuloma          
PR bleeding          
(D) Death          
(E) Clavien-Dindo 
classification 
         
I          
II          
III          
IV          
V          
Table 1: Data Collection Sheet  
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Data analysis and management 
The chi squared test, Student’s t-test, ANOVA and their non-parametric equivalents 
will be used for tests of hypothesis where appropriate. Data will be collected and 
entered directly into an excel spreadsheet. The data will be coded and double entered 
into the spreadsheet. Data will then be analysed and managed in the statistical 
software package, Stata version 12.1. Means, standard deviations, ranges and 
histograms will be used to describe continuous data while medians, interquartile 
ranges, pi-charts and bar-graphs will be utilised for categorical data.  
Ethics approval 
Ethics approval will be sought from the University of Cape Town Human Research 
Ethics Committee and the Groote Schuur Surgery Departmental Research 
Committee. 
Work Plan 
 February 2013- March 2013:  Ethics and Departmental Research Committee
approval and literature review.
 March 2013- April 2013: Data collection and analysis.
 April 2013-May 2013: Write up and submission of first draft.
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The construction of an ileostomy is used increasingly to reduce the risk of pelvic 
sepsis after very low rectal anastomosis. The actual benefit from a defunctioning 
stoma will depend on the successful reversal of the stoma being associated with 
minimal risk. Although closure of ileostomy is regarded as a fairly minor procedure, 
it is still associated with significant morbidity and mortality. This review of the 





Ileostomy is derived from 2 Greek words, eilos (twisted bowel) (1) and stoma 
(mouth) (2), literally translated to mean a hole in the twisted part of the bowel, i.e. 
the ileum. The more refined definition of an ileostomy being the surgical creation of 
an opening in the ileum through the abdominal wall to allow for preferential drainage 
of the intestinal contents. 
 
 
HISTORY AND EVOLUTION OF ILEOSTOMIES 
There have been numerous advances and developments in the creation of both 
ileostomies and colostomies as we know them today (3). Various Greek scholars 
including Hippocrates (460-377BC) and Claudius Galen (131-201AD) recognised 
that injuries to the bowel were life threatening, but did not know the reason behind 
this or how to treat them (3). With the discovery and use of guns in the 14th century, 
gunshot wounds became common, and there was an associated increase in bowel 
injuries which resulted in a high morbidity and mortality. Most injuries were 
managed expectantly as little was known about how to fix them. Those pioneering 
surgeons who dared to fix them ended up with exceptionally high rates of peritonitis, 
anastomotic leaks and death. The patients who survived these injuries did so despite 
the surgeons’ skills and knowledge, and ended up with enterocutaneous fistulae. The 
Swiss Alchemist and physician, Theophrastus Bombastus Von Honenheim (1493-
1541) noted that patients got better after creation of an intestinal fistula (3). 
The first documented stoma creation was performed by the British surgeon, William 
Cheselden (1688-1752) on a 73 year old woman who had a strangulated umbilical 
hernia with 55cm of dead bowel, for which he carried out a resection and brought out 
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a piece of her intestine onto the abdominal wall. She survived several years post 
operatively despite limitations in wound and ostomy care (3). 
Since then numerous surgeons performed ileostomies with disastrous complications 
and death. Some of these complications were related to poor aseptic techniques, 
inadequate anaesthesia, anastomotic leaks, peritonitis and poor wound care. As 
anaesthesia and aseptic techniques improved from the mid-19th –20th century more 
operations were performed successfully. The German Surgeon, Baum has been 
credited for performing the first documented ileostomy in 1879 (3).  
The most morbid complication was noted to be a high stoma output termed 
“ileostomy dysfunction” (2). This entity was noted by Crile & Turnbull (1954) to be 
as a result of serositis secondary to the exposed serosa of the ileostomy on the 
abdominal wall. They rectified this problem by excising the seromuscular layer of 
the exposed portion of the bowel, everting the mucosa and submucosal layers of the 
bowel wall over the ileostomy and suturing it to the abdominal wall (4). The 
commonly performed Brooke ileostomy done today, involves evagination of the full 
thickness of the bowel wall and suturing the edge to the abdominal wall (5). It was 
first described by Bryan Brooke in 1952 and has the advantage of preventing skin 
excoriation, allows better fitting of the stoma bag at the base of the ileostomy and 
hence prevents leakage (6). 
Turnbull & Weakley first described the loop ileostomy in 1971 (7)-(9). Prior to this 




(a)Indications for a temporary ileostomy 
The following are indications for the formation of a temporary loop ileostomy (10): 
 To protect complex anastomoses such as following an ileoanal anastomosis 
or a low anterior resection for rectal cancer. 
 To defunction an ileoanal pouch anastomosis (IAPA) following 
proctocolectomy in patients with Ulcerative colitis (UC), Familial 
Adenomatous Polyposis(FAP) & Hereditary Non Polyposis Coli Colorectal 
Cancer (HNPCC). 
 To defunction patients who have severe perianal fistula disease due to 
Crohn’s disease. 
 To divert the faecal stream away from a vulnerable distal bowel anastomosis 
done as an emergency procedure in a heavily contaminated acute abdomen 
secondary to bowel perforation or trauma. 
 For management of an anastomotic leak.  
 Management of perianal/perineal sepsis. 
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 To divert and allow healing in cases of complex rectovaginal, rectourethral or 
pouch vaginal fistulae. 
 To manage obstetric complications. 
 Patients with radiation proctitis 
 Patients with anal stenosis. 
 
(b)Indications for a permanent ileostomy 
Indications for permanent end ileostomies include: 
 To relieve distal obstruction due to unresectable pelvic malignancy (10). 
 To provide a permanent defunctioning solution in patients in whom a 
restorative procedure is not possible e.g. Total proctocolectomy in Crohn’s 
disease or patients with FAP, and a low lying rectal cancer involving the anal 
sphincter complex. 
 As a last line of therapy for patients with intractable idiopathic constipation 
(11). 
 Paraplegic patients. 
 Patients with faecal incontinence unresponsive to other forms of treatment 
(10).  
 
(c)Ileostomy Versus Colostomy debate 
The main reason for performing a defunctioning ileostomy or colostomy is to divert 
the intestinal content away from a distal anastomosis to allow it to heal adequately 
and to reduce the rate of leakage related re-interventions (12). This can be done with 
either a colostomy or an ileostomy. 
The ileostomy versus colostomy debate has raged for many years and there is still no 
consensus as to which is superior. A recent met-analysis and systematic review 
conducted by Rondelli et al (2009) (12) looked at 5 RCTs and 12 comparative 
studies and concluded that the rate of sepsis and prolapse were lower in patients with 
loop ileostomies (LI) compared to those with loop transverse colostomies (LC). 
However, they also reported a lower incidence of bowel obstruction after closure of 
LC compared to LI, but this was only significant in those patients with rectal cancer.  
 A met-analysis done by Güenaga et al (2008)(13) and Lertsithichai (2004) (14) 
arrived at the conclusion that stoma prolapse occurs more commonly in LC than with 
LI but could not make any recommendations as to which of the two techniques was 
better as the sample sizes of the analysed RCTs were too small. 
These met-analyses contained very heterogeneous patient populations. In an attempt 
to rectify this problem, a retrospective review of 462 patients done by Rullier et al 
(2001) (15) on a more homogenous group of patients (rectal cancer patients only 
with similar demographics) showed that the complication rate was significantly 
higher in LC (34%) compared to LI (12%). The risk of intervening post stoma 
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construction and closure was significantly higher in LC (22%) compared to LI (9%). 
Thus it would appear that LI is better than LC in patients with rectal cancer.  
Only 2 small RCTs (Gooszen 1998 (16) & Law 2002 (17)) have so far favoured LC 
over LI. With the current evidence leaning in favour of loop ileostomies albeit from 
small RCTs, retrospective studies, systematic reviews and met analyses, larger, well 
designed RCTs are required to provide a better answer as to which transitory stoma 
is indeed better.  
 
(d)Ileostomy in patients with low rectal cancer 
Colorectal cancer is the third most common cancer in men and second most common 
in women worldwide (18). It is the third most common cancer in the world and the 
fourth most common cause of death (19). Colorectal cancer surgery has evolved 
remarkably over the last decade.  Anterior resection with total mesorectal excision 
(TME) has become the standard operation for resectable middle and lower third 
rectal cancers that do not involve the anal sphincter complex. 
 Many surgeons prefer to defunction the primary coloanal anastomosis using a 
covering loop ileostomy while others do not. There are several factors which 
influence this decision. These include surgeon preference, the presence of 
comorbidities, recent radiotherapy, technically challenging operation, steroid 
therapy, severe contamination during the surgery, incomplete circular stapler 
doughnuts, failed hydro pneumatic leak test and height of the anastomosis (10), (20). 
For low lying rectal lesions (i.e. between 2cm and 5cm) the leak rates are 
significantly high if there is no diverting ileostomy (44.4% versus 12.7% 
respectively) (21).  These leak rates are thought to occur either secondary to 
devascularisation of the rectal stump or large area created by the TME and is 
compounded by poor anastomotic healing post neoadjuvant radiotherapy (12). 
Chronic medical conditions like renal dysfunction, diabetes mellitus and chronic 
liver disease all result in chronic malnutrition and poor wound healing and are 
indications for a covering loop ileostomy. Radiotherapy and steroid therapy similarly 
cause delayed wound healing and high rates of anastomotic leaks thereby mandating 
formation of a loop ileostomy. 
 
TECHNIQUE OF ILEOSTOMY CONSTRUCTION 
Ileostomies can be performed open or may be performed using standard laparoscopic 
techniques or through single incision laparoscopic procedures (22). 
The open technique of loop ileostomy construction involves the following steps: (See 
Figure 1) 
 A circular incision is made over a premarked stoma site on the patient’s 
abdomen.  
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 Dissection is carried down to the rectus sheath and the sheath is incised in a
cruciate manner, the muscle layer retracted away and the peritoneal cavity
entered.
 A loop of small bowel about 20-30cm from the terminal ileum is brought out
through the trephine hole onto the skin using Babcock forceps or a Jacques
catheter ensuring there are no twists in the bowel.
 The proximal end is marked with a suture. An enterotomy involving 80% of
the circumference is made on the antimesenteric side of the ileum.
 The proximal end of the ileostomy is spouted while the distal end is sutured
flush with the skin using vicryl 2/0.
Figure 1: Construction of a loop ileostomy (23) 
COMPLICATIONS OF ILEOSTOMY CONSTRUCTION 
Ileostomy formation has its own complications and these can be classified as early or 
late, physiological, functional or psychological (22).  
Early complications (up to 30 days after the operation) include haemorrhage, stomal 
pain, retraction (17%) (22), ischaemic necrosis, detachment, early skin excoriation 
and peristomal abscess formation (10). 
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 Late complications (more than 30 days after the operation) include stoma prolapse 
(<4%), parastomal herniation (1-3%), stenosis and up to 25 % patients develop small 
bowel obstruction post ileostomy formation (10). Peristomal fistula formation is also 
a complication of ileostomy formation and is seen most commonly in patients with 
Crohn’s disease. The causes of fistulae include deep placement of a suture or 
mechanical causes such as leakage or injury from stoma appliances (10). In patients 
with Crohn’s disease fistula formation around the ileostomy is a sign of disease 
recurrence until proven otherwise (10).  
 Other late complications include high output of the ileostomy, leading to 
dehydration and renal dysfunction, and peristomal skin problems such as dermatitis 
(23), ulceration, fungal infections and folliculitis (22). These peristomal conditions 
occur in 18.3-61% of patients with ileostomies. The incidence of dehydration in 
patients with ileostomies varies from zero to more than 70% (10). Ischaemia of an 
ileostomy is a rare (1-5%) complication but common in obese patients in whom the 
large abdominal pannus causes increased mesenteric tension and strangulation of the 
ileostomy (22). Complication rates of defunctioning ileostomies range between 5-
100% (10). Of those patients who have ileostomies, between 10-70% of them will 
have a complication related to their stoma (22). 
The other major complication of ileostomy formation which is often under stated in 
the literature is permanence of the stoma i.e. non-closure of stoma. The incidence of 
non-closure reported in the literature ranges from 0-19% (10). Some of the risk 
factors associated with non-closure in patients with colorectal cancer include 
occurrence of complications after the index surgery such as symptomatic 
anastomotic leaks, old age of the patient, advanced cancer disease and adjuvant 
chemotherapy (20). Non-closure has a serious impact on the quality of life of these 
patients affecting their psychosexual functioning, altered self-image, difficulties with 
long term stoma care, depression, social problems and financial repercussions 
(10),(24),(25). These patients often succumb to complications of long term 
depression and have a poor survival rate. 
 
 
B. CLOSURE OF ILEOSTOMY 
 
 
(1)TIMING OF CLOSURE 
There is significant morbidity associated with loop ileostomy formation. The 
proponents of early closure argue that early closure will improve the quality of life of 
the patient, reduce ileostomy related morbidity and still protect a distal anastomosis.  
Ileostomy closure is usually performed three months after the primary operation to 
allow for wound healing to occur and time to allow for the development of any 
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complications which may occur so that they can be dealt with appropriately prior to 
considering closure (26). In addition this time also allows the inflammation, 
induration and oedema within the abdomen and around the ostomy site to resolve. 
The intra-abdominal adhesions also become less vascular and fibrotic.  Closure after 
8.5 weeks has been reported to be associated with lower postoperative complications 
(27).  
Several prospective, non-randomised studies have suggested that early closure of 
ileostomies i.e. within two weeks, is possible in a select group of patients (27), (28), 
(29). However, there is currently no consensus over which selection criteria should 
be used for these patients. Some proposed criteria include patients with normal stoma 
function, absence of signs of local and systemic infection, absence of a demonstrable 
leak on water soluble contrast studies done on 7th postoperative day and patients who 
are not on any steroid therapy (28).  
A randomised controlled trial (RCT) by Alves et al (30) allocated a select group of 
patients to either early closure (EC) on day 8, or late closure (LC) on day 60. The 
overall morbidity was similar (31% in EC and 38% in LC group). Furthermore 
overall surgical complications and reoperation rates were similar in both groups. 
However wound complication rates were higher in the EC group. Small bowel 
obstruction (16% vs. 3%) and medical complications (15% vs. 5%) were higher in 
the LC group compared to the EC group.  
Delayed closure is considered to be closure beyond 12 weeks (10). The main reasons 
for this include the presence of a symptomatic anastomotic leak, enterocutaneous 
fistula, administration of postoperative chemotherapy following the primary surgery, 
cancer recurrence, progressive malignancy and postponement of the procedure as 
ileostomy closure is not deemed an operation of high priority (10) (20). 
In our setting 3 months is the usual time frame within which ileostomies are closed. 
Closure may be considered earlier in patients who are struggling to manage their 
ileostomies due to high output with resultant dehydration and repeated admissions to 
correct the same. Even in these cases two months is usually seen as our early closure 
time.  
It is standard practice to perform a contrast radiographic examination (loopogram) to 
exclude an efferent limb obstruction or leak from a previous pelvic or other 
anastomosis, prior to closure of the ileostomy.  
 
 
(2)TECHNIQUE OF ILEOSTOMY CLOSURE 
 Ileostomy closure techniques are quite standard and include a simple hand sewn 
anastomosis or a stapled anastomosis. The main steps involved in closure of a loop 
ileostomy include: (See Figure 2) 
1. A peristomal incision is made around the stoma.  
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2. The incision is deepened and dissection carried down to the subcutaneous 
tissue. 
3. A dissection plane is developed between the bowel wall and the subcutaneous 
tissue and carried on in a circumferential manner until the rectus sheath is 
reached. 
4. The small bowel is then dissected free from the rectus sheath taking care not 
to injure the bowel wall during this process.  
5. Eventually the peritoneal cavity is entered and the remainder of the adhesions 
are divided using a finger sweep manoeuvre.  
6. The loop of ileum is then taken out of the abdominal cavity and the 
mucocutaneous junction and skin rim are excised and the proximal everted 
end of the stoma is unfolded using sharp dissection. 
7. The freshened edges of the enterotomy are closed using absorbable sutures 
such as vicryl 2/0 in a continuous or interrupted manner. If the edges of the 
stoma appear to be in a poor condition, then debridement of the edges and an 
end to end anastomosis is performed using vicryl 2/0. 
 A functional end to end with stapled anastomosis may also be done as an 
alternative to a hand sewn procedure.  
8. The sheath is then closed. 
9. The skin is closed using skin staples or interrupted nylon suture.  The skin 
may also be closed using a circular purse string suture or left open so that 
healing by secondary intention occurs. The rationale for this type of closure is 
to minimise postoperative wound infection especially in those patients who 
have had their stomas for a long period of time.   
 
(a)Hand sewn Versus Stapled anastomosis 
There have been numerous studies comparing the outcomes after a hand sewn versus 
a stapled anastomosis. A previous RCT, with about 70 patients in each study arm, 
concluded that the rate of bowel obstruction was higher in the stapled group (14%) 
compared to the hand sewn (3%) group, while the mean hospital stay, readmission 
and reoperation rates did not differ significantly between the two groups (31). The 
only advantage perceived using a stapled anastomosis according to this study was a 
shorter length of stay in hospital and a faster surgical time. Several small 
retrospective studies have also confirmed that the stapled anastomosis results in 
shorter length of hospital stay, lower rates of anastomotic leakage and reduced 
overall morbidity compared to a hand sewn procedure (32), (33). In addition, to 
faster surgical time some studies claim an overall reduction in hospital costs as well 
(34). Several studies, on the other hand, have shown no difference in the duration of 
surgery, length of hospital stay, rate of anastomotic leak or time to achieve a bowel 
action whether the anastomosis was stapled or hand sewn (35), (36). The HASTA 
trial comparing hand sewn anastomosis and stapled anastomosis with a target of 334 
patients recruited, is yet to reveal its results and shed more light on whether a hand 







Figure 2: Closure of Ileostomy (23) 
 
 
COMPLICATIONS OF ILEOSTOMY CLOSURE 
Complications after ileostomy closure are varied and are associated with significant 
morbidity and mortality rates. Ileostomy closure should not be considered a routine 
procedure as it necessitates another hospital admission and carries its own risks (38). 
The morbidity rate varies between 3 to 30 % and the mortality rate between 0 to 4%. 
Most of these rates have been derived from very small retrospective studies done in 
USA, Spain, Turkey and Europe (27), (39), (40), (41), (42), (43). A recent large 
retrospective study undertaken by Sharma et al looked at 5,401 patients and 
demonstrated a major complication rate of 9.3% and a mortality rate of 0.6% (38).  
The main surgical complications noted after an ileostomy closure include small 
bowel obstruction (SBO), wound infection, anastomotic leaks, fistulae formation,  
bleeding from staple lines and incisional hernia formation (40)-(46).  
 
 
(a)Small Bowel Obstruction 
The incidence of SBO ranges from 0 to 15% (10). In most patients the SBO resolves 
with just conservative management. In those patients who need operative 
management of bowel obstruction, the aetiology of the obstruction is usually intra-
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abdominal adhesions. Other less common causes of bowel obstruction found 
intraoperatively include strictures, intramural oedema and intramural hematoma. In 
some cases no cause is found for the obstruction (10). Narrowing of the ileal lumen 
from oedema after bowel anastomosis compounded by the fact that the distal limb 
has a narrow lumen due to previous defunctioning is a recognised cause for the SBO 
post ileostomy closure (10). Some studies have reported a lower incidence of bowel 
obstruction after stapled anastomosis while others have shown that the type of 
closure does not make a difference to the incidence of complications (35), (43),(47), 
(48), (49). 
Certain patient groups have been noted to have a higher rate of complications post 
ileostomy take down. It has been noted that patients with UC who have had IAPA 
have a higher incidence of SBO than other patients possibly due to the increased 
number of adhesions secondary to increased bowel manipulation during the primary 
surgery, therefore making ileostomy closure more difficult and longer (10),(27). It 
has also been postulated that the short length of the mesentery, extent of 
inflammatory disease affecting the remainder of the bowel and increased traction 
placed on the mesentery during ileostomy closure make it technically more difficult 
(10),(27). It is still unclear as to whether the adhesions from the primary operation or 
that from the ileostomy closure operation contribute to SBO in this group of patients 
(10). 
The type of incisions utilised during the surgery itself i.e. parastomal, extended 
parastomal or midline incisions do not influence the development of a SBO post 




Wound infection is also a common complication after ileostomy closure. It presents 
as either some erythema or induration around the wound edges to purulent discharge 
from within the wound (10). This can eventually lead to fistula formation as well as 
wound sepsis. The rate of wound infection is reported as 18.3% (10). Various wound 
closure techniques have been advocated in an attempt to minimise the rate of wound 
infection. These include leaving the wound partially open, completely open, use of 
subcuticular purse string sutures and standard interrupted primary wound closure. It 
has been found that subcuticular purse string sutures have a lower wound infection 




Anastomotic leak rates are reported to range from 0 to 8% (10). The anastomotic leak 
rate is not associated with the type of closure performed. These leaks can be 
subclinical or overt, and patients may present with overt peritonitis or enteric fistulae 
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(10). They need to be managed surgically, or may be managed conservatively e.g. in 
the case of a low output enterocutaneous fistula.  
(d)Enterocutaneous Fistula
Enterocutaneous fistula rates range from 0.5 to 7% (10). Several different types of 
fistulae can form post operatively and they include enterocutaneous, enteroenteric, 
enterovesical and enterovaginal (10). Some fistulae may heal spontaneously while 
others require bowel rest and parenteral nutrition. Those fistulae which result from 
anastomotic breakdown require surgical closure. Patients with Crohn’s disease who 
develop fistulae post operatively are preferentially managed medically as repeated 
reoperations increases the risk of postoperative complications, and subsequent 
operations predispose them to development of short bowel syndrome from serial 
bowel resections. 
(e)Incisional Hernias
Incisional hernias develop in 1-12% patients (10). This is usually a late complication 
seen several months post closure (46). The management is by mesh repair of the 
hernia.  
(f)Risk Factors for developing complications
There have been many studies done to try and determine whether there are certain 
factors which are associated with or may predict the complication rate after an 
ileostomy closure. A recent study demonstrated the association between pre-
operative hypoalbuminaemia and anaemia and higher complication rate following 
ileostomy closure (45). Other studies have shown that there are no differences in 
complication rates whether a trainee or consultant performed the closure (50). 
Neoadjuvant chemotherapy does not seem to predict the incidence of complications 
seen after closure (38).  
The time interval to ileostomy closure has been reported in some studies as not being 
a significant contributor to development of postoperative complications while other 
studies have demonstrated that a longer duration between ileostomy formation and 
closure causes increased postoperative complications (38), (51). Patients who had 
benign indications for stoma formation (like diverticulitis) have a higher rate (20%, 
n=123) of postoperative complications as they were seen to have their stomas for a 
longer duration than those who had rectal cancer (41). The only complication noted 
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Background:  Loop ileostomies are often used to protect a difficult coloanal or 
ileoanal anastomosis and dampen the clinical effects of an anastomotic leakage (2). 
Ileostomy closure itself is associated with considerable morbidity and mortality and 
is not just a routine operation (1). 
Objective: The aim of this study was to audit the complications seen after ileostomy 
closure at Groote Schuur Hospital. 
The primary outcome was to determine the complication rate. The secondary 
outcome was to determine if there was any association between the various 
perioperative, operative and patient factors and the complications observed. 
Method:   All patients who underwent closure of ileostomy from January 2008 to 
December 2012 were included in the study.  Individual patient records were used to 
extract patient demographics, perioperative variables, operative variables and 
postoperative complications retrospectively. The complications were graded using 
the Clavien- Dindo classification system 
Results: A total of 80 patients were included in the study. There were 45 males and 
35 females with a mean age of 50.6 years (18-81yrs). The median time to achieve 
bowel movement post closure was 3 days (range 2-16 days). The overall 
complication rate was 47.5%. Major complications were seen in 35% (28/80) of 
patients and these included bowel obstruction (14% 11/80), enterocutaneous fistula 
(6% 5/80), incisional hernia (4% 3/80) and stricture (1% 1/80). Minor complications 
accounted for 25% (18/80) of the total complications of which wound infection 
accounted for 21% (17/80). Medical complications made up 21% (17/80) of all 
complications of which the most common complication was pneumonia (6% 5/80). 
Two patients (2.5%) died after closure from medical complications. After using a 
stepwise logistic regression model and adjusting for confounders, renal dysfunction 
was found to be a statistically significant determinant for the development of 
complications (OR=3.31, p=0.022, 95% CI=1.186 to 9.242). The pathology 
(p=0.177), type of closure (p=0.285) and the surgeon (p=0.064) did not show any 
statistically significant association with development of complications. 
Conclusion: Ileostomy closure is associated with significant morbidity. Renal 
dysfunction is associated with a high complication rate.  
Keywords:  loop ileostomy, complications of closure, morbidity, mortality 
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Abbreviations:  TME=Total mesorectal excision, BMI =Body mass index, SBO= 
small bowel obstruction, DVT= Deep venous thrombosis, UTI=urinary tract 
infection, FAP=Familial adenomatous Polyposis, PJS=Peutz Jegher’s syndrome, 
RVF= rectovaginal fistula, ASA=American Society of Anaesthesiologists’ 
classification 
INTRODUCTION 
A loop ileostomy has been utilised widely in elective colorectal surgery to protect a 
very low rectal anastomosis such as following a TME or restorative 
proctocolectomy, which are considered high leak risk anastomoses, as well as for 
diversion purposes following emergency surgical procedures. Ileostomy construction 
has been shown to dampen the clinical effects of a leak as well as to reduce the rate 
of intervention post leakage (2). However the benefits of the covering ileostomy have 
to be weighed against the problems associated with its closure. 
The most commonly reported complications after ileostomy closure include bowel 
obstruction, surgical site infection, anastomotic leaks, fistulae formation and 
incisional hernia formation (3)-(9). Although it is considered to be a routine 
operation, closure of ileostomy is associated with significant morbidity. Furthermore 
it requires another hospital admission, and also utilises the same if not more 
resources post operatively than the primary procedure necessitating its formation (1). 
The aim of this study was to document the incidence of and identify risk factors for 
postoperative complications after loop ileostomy closure at Groote Schuur Hospital. 
PATIENTS AND METHODS 
The study was approved by the Human Research Ethics Committee of the Faculty of 
Health Sciences of the University of Cape Town. All patients who were admitted for 
closure of ileostomy to the colorectal unit at Groote Schuur Hospital from January 
2008 to December 2012 were included in the study. 
Individual patient medical, anaesthetic and nursing records were reviewed to extract 
information retrospectively. Inclusion criteria were all patients with previous loop 
ileostomy constructed during both elective and emergency surgery during the above 
time period.  
The following information was extracted from the patient records: patient 
demographics, indication for ileostomy, comorbidity status, BMI, length of hospital 
stay, duration of stoma, time taken to achieve bowel movement after closure, 
performance status of the patient, administration of preoperative chemotherapy or 
radiotherapy or both, experience level of surgeon performing the operation (junior 
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consultant or registrar), duration of the surgery, type of anastomosis performed (hand 
sewn or stapled) and whether the patient required re-operation or not. 
The complications observed were divided into 3 main groups, major, minor and 
medical complications. The major complications included the occurrence of SBO, 
anastomotic leaks, fistulae, hernia and stricture. Minor complications included 
surgical site infection, bleeding per rectum and occurrence of a stitch granuloma. 
Medical complications included pneumonia, UTI, line sepsis, cardiac complications, 
renal failure, anaemia, DVT and allergic reaction to medication. The frequency of 
these complications was then recorded for each patient. 
The 30 day outcomes of the patients was graded from I-IV using the Clavien-Dindo 
scoring system (See appendix 1). 
 
(i)Surgical Technique 
All patients had a radiological contrast study (loopogram) done prior to closure to 
rule out any distal bowel obstruction and leaks. The patients did not receive any 
bowel preparation prior to closure. 
At the operation all patients received a single dose of prophylactic antibiotics 
(Cefazolin 1g IV) about 30 minutes prior to the skin incision. A peristomal skin 
incision was used and none of the patients needed a laparotomy for the closure. 
Standard loop ileostomy closure was performed using either a single layer hand sewn 
end to end anastomosis with vicryl 2/0 absorbable suture or a functional end to end 
anastomosis with a 60mm linear GIA stapler. 
All operations were performed either by a registrar under the supervision of a junior 
consultant, or by a junior consultant with a registrar as the first assistant. 
 
(ii)Data Analysis 
All the data was entered into an Excel data work sheet directly. The data was then 
coded and double entered into a statistical software package (Stata version 12.1) for 
analysis. Descriptive statistics were utilised to analyse the data. The chi squared test 
and its variants, Student’s t- test and logistic regression was used to analyse the 
variables and their outcomes. 
 
RESULTS 
There were 88 patients who underwent closure of ileostomy between January 2008 
and December 2012. The data was incomplete in eight patients and they were 
excluded from the data analysis.  
Of the remaining 80 patients 45 patients were male and 35 were female with a mean 
age of 50.6 ± 15.7 years (range 18-81 years). 
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Majority of the patients were of mixed race origin (n= 51). Sixteen patients were 
white, 11 were black and 2 were of Indian origin. Only 43 of the 80 patients had BMI 
recorded. The mean BMI was 26 with a median of 25.64 (range 7-40.64). The patient 
characteristics are summarised in Table 1. 
 
Total number of patients  N = 
80 
Males= 45                       Females = 35  
Age (mean ± SD) years 50.6 ± 15.7 Range 18 - 81 
Race  Mixed race                            51 (63.75%) 
White                                    16 (20%) 
Black                                    11 (13.75%) 
Indian                                    2 (2.5%) 
 
BMI (mean ± SD) (kg/m2) 
 
26.0 ± 6.73  Range 7.00 – 40.64 
Co-morbidities 
 
Diabetes                                8(10%) 
Hypertension                        25 (31.25%) 





Smoking                               42 (53.1%) 
Immunosuppressive therapy 2 (2.5%)  
 







Unemployed                          22 (27.5%) 
< 4000                                   49 (61.25%) 
4000 - 8000                           3 (3.75%) 
>8000                                    3 (3.75%) 




Table 1: Patient characteristics 
 
Eight (10%) patients had diabetes, 25 (31.25%) had hypertension, and 28 (35%) had 
renal dysfunction (creatinine raised to 1.5 times of baseline levels).There were 42 
patients who smoked and 2 were on immunosuppressive therapy.  








The most common indication for loop ileostomy formation was following a TME for 
rectal cancer (51%) as shown in Figure 1. Other primary indications for ileostomy 
formation included ulcerative colitis (18%), Crohn’s disease (9%), diverticular 
disease (6%), intra-abdominal sepsis (5%), FAP (5%), RVF (3%), tuberculosis (1%) 













rectal cancer crohn's disease





Figure 2: Duration of Ileostomy prior to closure 
The duration of the ileostomy prior to closure is shown in Figure 2. The mean 
duration of ileostomy prior to closure was 8.23 ±4.42 months, with a median of 7 
months (range 2-24months). This long duration is due to the prolonged waiting time 
in a resource stretched hospital. 
Forty two (52%) of the operations were performed by registrars while 38(48%) were 
performed by junior consultants.  
 The majority of the anastomoses performed were hand sewn (n=71, 89%), and only 
9 (11%) were stapled anastomoses. 
37 
 
The duration of the surgery is shown in Figure 3. The duration of surgery varied 
from 30 to 183 minutes with a mean of 86 ± 32.76 minutes. The duration of the 
surgery did not correlate with the development of complications (p= 0.58, OR=1.0, 




Figure 3: Duration of the surgery 
 
The mean length of hospital stay was 7.04 ± 6.57 days with a maximum duration of 











The median time to achieve bowel movement was 3 days (range 2-16 days). One 
patient took 16 days to open bowels, while one patient had missing data. First bowel 
movements occurred mostly between days 1 and 5. Fewer bowel movements 
occurred between days 6 and 10.  The time taken to achieve bowel movement is 








Two patients died post ileostomy closure (See Figure 5). Overall, 38 (47.5%) 
patients developed complications post closure of ileostomy (See Table 2).  Major 
complications accounted for a large proportion of complications (n=28), while minor 
(n=18) and medical complications (n=17) were less common. More than half 
(52.6%) of the complications were seen in patients with rectal cancer while 6 of the 7 
patients with Crohn’s disease developed complications. Patients with sepsis, RVF, 
PJS and traditional enemas did not develop any complications (See Table 2) but 
rectal cancer was the most common indication for surgery so the denominator is 
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Kaplan-Meier: time to first bowel movement after closure
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N= 2  
Rectal 
cancer 
 N = 41 
20 
 
13  5 9  1  
Crohn’s 
Disease 
N = 7 
6  
 
4  4  2  0 
Diverticular 
disease 
N = 5 
2  
 
2  2 1  0 
Ulcerative 
colitis 
N = 14 
6 
 
5 4  3  0 
TB 
N = 1 
1  
 
1  1  1  0 
FAP 
N = 4 
3  
 
3 2  1  1  
Others: 
Traditional         
Enema N=1 
RVF     N=2 
Sepsis   N=4 
PJS       N=1 
0 0 0 0 0 
 
Table 2: Complications post ileostomy closure 
 
(a)Major complications 
Major complications were seen in 28 (35%) patients (see Table 2). The major 
complications included SBO (n=11, 14%), enterocutaneous fistula (n=5, 6%), 
incisional hernia (n=3, 4%), stricture (n=1, 1%). Ten percent of the patients had 
multiple major complications. One patient developed an anastomotic leak, after 
developing an enterocutaneous fistula and stricture 4 weeks post closure. 
(b)Minor complications 
Minor complications occurred in 18 (25%) patients. Of the minor complications 
noted, 21% (n=17) had wound infection, one patient had bleeding per rectum, one 
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patient had constipation and three patients had stitch granulomas which needed 
excision. Only one patient had multiple minor complications.  
(c)Medical complications  
Medical complications were seen in 17 (21%) patients and included pneumonia (n=5, 
6%), UTI (n=3, 4%), line sepsis (n=2, 3%), anaemia (n=1, 1%) cardiac complications 
(n=1, 1%), DVT (n=1, 1%) and allergic reaction (n=1, 1%).Three (4%) patients had 
multiple medical complications.  
(d)Deaths 
Two patients died of medical complications. One died on day 17 of ventilator 
associated pneumonia and the other on day 43 of complications of recurrent DVT.  
The types of complications are summarized in Figure 5. 
 
 
Figure 5: Types of complications post ileostomy closure 
 
 
The reoperation rate was 11.25% (n=9). The indications for reoperation were stitch 
granulomas (n=3), incisional hernias (n=2), enterocutaneous fistula (n=1), relook for 
suspected leaks (n=2) and incision and drainage of an abscess in the wound (n=1).  
The 30 day Clavien-Dindo grading system classified fifty seven (71%) patients into 










Factors associated with development of complications 
Twenty percent (n=16) of the patients received adjuvant chemotherapy between their 
rectal excision and ileostomy closure. Twenty one percent (n=17) had received 
preoperative radiotherapy prior to the rectal excision for which the ileostomy was 
created. The use of preoperative chemotherapy and preoperative radiotherapy did not 
correlate with the development of complications in the rectal cancer group of 
patients. 
Univariate analysis of potential risk factors associated with development of 
complications showed that renal dysfunction was the only factor which was a 
statistically significant determinant of the development of complications (OR=3.38 
p=0.014, 95% CI 1.280-8.911) (See Table 3). 
 
Risk Factor Odds Ratio p-value  95%CI 
Smoking 
 
1.23 0.642 0.511 to 2.573 
Diabetes 
 
1.86 0.418 0.414 to 8.384 
Hypertension 
 
1.94 0.178 0.741 to 5.067 
Renal dysfunction 
 
3.38 0.014 1.280 to 8.911 
Type of closure 
 
0.26 0.110 0.510 to 1.352 
Pathology 
 
0.88 0.177 0.737 to 1.058 
Age 
 
1.02 0.304 0.987 to 1.044 
Duration of 
Surgery 
1.00 0.580 0.99 to 1.02 
 
Table 3: Univariate analysis  
 
Multivariate analysis of risk factors was performed using a forward stepwise logistic 
regression model. The analysis was adjusted for confounders which included age, 
gender, performance status, duration of ileostomy prior to closure, duration of 
surgery, ethnicity and annual income. Other variables which were entered into the 
stepwise logistic regression model were smoking, diabetes, hypertension, renal 
dysfunction, type of closure, surgeon, and pathology.  
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 Renal dysfunction was found to be a statistically significant determinant for the 
development of complications (OR=3.31, p=0.022, 95%CI=1.186 to 9.242) (See 
Table 4). 
Complications Odds Ratio P-value 95%CI 
Renal dysfunction 3.31 0.022 1.186 to 9.242 
Surgeon 0.39 0.064 0.145 to 1.054 
Annual income 0.58 0.094 0.311 to 1.096 
Type of closure 0.39 0.285 0.0681 to  2.205 
Table 4: Multivariate analysis 
Risk Factors for development of Major Complications 
Thirteen out of 28 patients with renal dysfunction developed major complications. 
However, renal dysfunction was not a statistically significant risk factor for the 
development of major complications on univariate (OR =2.14, P-value= 0.119, 95% 
CI= 0.823 to 5.55) and multivariate analysis (OR= 3.60, P-value= 0.224, 95% CI= 
0.46 to 28.46). 
DISCUSSION
Although closure of ileostomy is regarded as a relatively minor surgical procedure, it 
does require a second hospital admission which is accompanied by considerable 
costs, and is associated with significant morbidity (1).  
In this study almost half the patients (47.5%) developed a complication which is 
much higher than that quoted in the literature.  The mortality rate was 2.5% which is 
within the reported range. Of the two patients who died of medical complications, 
one had rectal cancer and the other FAP and both were elderly males, with renal 
dysfunction and a poor performance status prior to closure. Most of the data 
regarding complications following ileostomy closure comes from a small number of 
reviews done in USA, Spain, Turkey and Europe reflecting a morbidity of 3-30% and 
a mortality rate of 0-4% (3), (4), (5), (10), (11). A recent study on 5,401 patients 
demonstrated a complication rate of 9.3% and a mortality rate of 0.6% (1). 
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The indications for the ileostomy closure in this study included a mixture of patients 
with both rectal cancer and inflammatory bowel disease mainly. Almost all (six out 
of seven) of the patients with Crohn’s disease and almost half (six out of fourteen) of 
the patients with ulcerative colitis developed complications. This could be one of the 
reasons for the overall high complication rate observed. 
However, on comparison of the individual complication types with that reported in 
literature, most complications fall within the expected reported range.  
In the present study, SBO occurred in 14% of patients, and is reported as 0-15% in 
the literature (12).  The anastomotic leak rate in this study was interestingly low (1 
patient, 1%) and occurred as part of multiple major complications. In the literature 
the anastomotic leak rate alone varies between 0- 8% (12). The enterocutaneous 
fistula rate of 6% in the present study was also in accordance with that reported (0.5- 
7%) (12).The rate of incisional hernia development was 4% and falls within the 
reported range of 1-12% (9), (12). The time taken for the hernia to develop in this 
study ranged from 3-17 months post ileostomy take down.  
The rate of surgical site infection of 21%, was higher than that reported in literature 
(18.3%) (12). This could possibly be explained by poor wound care related to 
patients having a higher threshold to come to hospital for follow up postoperatively 
due to financial constraints or long travelling distances. Most of our patients were of 
lower socioeconomic status. Another problem is the inadequate wound care provided 
at local clinics within the patient’s home area. 
The reoperation rate in this study was 11% which is much higher than that reported 
in the literature (6-8%) (5), (13).  
In an attempt to identify any possible risk factors which may have contributed to this 
high complication rate, univariate and multivariate analysis were performed. Renal 
dysfunction was the only identifiable factor found on both univariate and 
multivariate analysis to be associated with a high complication rate. This is in 
keeping with the findings of Sharma et al who described a 2.5 times risk of 
developing major complications in patients with renal dysfunction (1). However 
renal dysfunction was not a statistically significant determinant for the development 
of major complications. This could possibly be due to the small sample size or the 
fact that there were too many variables and few major complications. 
Patient factors such as age, gender, performance status, ethnicity, hypertension, 
diabetes, pathology and annual income did not influence the development of 
complications. Perioperative factors such as experience level of the surgeon, type of 
closure and duration of surgery did not contribute to development of complications. 
This is in keeping with the literature (1), (14), (15), (16).Pre-operative radiotherapy 
and chemotherapy also did not influence the development of complications in the 
rectal cancer group, which has been quoted in the literature as a significant 
contributor for the development of minor complications (17). 
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The sample size in the present study was not big enough to determine if the possible 
risk factors were significant or not. However, this does not explain the overall high 
complication rate observed, implying that there may be other risk factors besides 
those which were measured in this study, and which may contribute to the 
development of complications post ileostomy closure. Environmental, genetic and 
sociocultural health seeking behaviour are possibly some factors which may require 
further investigation in the future as plausible contributory factors.  
Some of the limitations of this study which could be improved upon in the future 
include a bigger sample population, randomisation of patients to eliminate bias, 
inclusion of other unmeasured variables in the study design such as patient health 
seeking behaviour patterns and HIV status of the patient.  
This study has several important clinical implications. Patients with renal 
dysfunction may benefit from early closure of their ilesostomies. In addition to just 
fast tracking them to surgery, the informed consent process should clearly include a 
warning about the increased likelihood of development of complications post 
operatively and a longer hospital stay. These patients are also likely to benefit from 
being in a high care unit post operatively rather than a general surgical ward. 
Although this may have cost implications in an already resource stretched 
environment, it may in the long term save the money that might be utilised to 
manage the complications in this group of patients.  
In conclusion, the complication rate observed post ileostomy closure in this study 
was high. The magnitude of these complications are attributable to a multifactorial 
causality in the South African setting. Renal dysfunction was identified as a 
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Appendix 1: Clavien-Dindo classification of surgical complications 
 
Clavien-Dindo Classification of Surgical Complications  
Grade Definition 
Grade  I Any deviation from the normal course without the need for pharmacological treatment or 
surgical, endoscopic and radiologic interventions 
Allowed therapeutic regimens are: drugs as antiemetics, antipyretics, analgetics, diuretics, 
electrolytes and physiotherapy. This grade also includes wound infections opened at the 
bedside  
Grade  II Requiring pharmacological treatment with drugs other than such allowed for grade I 
complications 
Blood transfusions and total parenteral nutrition are also included 
Grade  III Requiring surgical, endoscopic or radiological intervention 
 III a Intervention not under general anaesthesia 
 III b Intervention under general anesthesia 
Grade  IV Life-threatening complication (including CNS complications)* requiring IC/ICU management 
 IV a Single organ dysfunction (including dialysis) 
 IV b Multiorgan dysfunction 
Grade  V  Death of a patient 
*Brain haemorrhage, ischemic stroke, subarrachnoidal bleeding, but excluding transient ischemic attacks. 
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